Chinese manufacturers dominated the 127GW of new wind turbines installed last year, but Siemens Gamesa remains streets ahead in offshore deployment and Vestas boasts the widest reach, new Global Wind ...

German giant Siemens Energy has shrugged off the threat posed by US tariffs after reporting one of its “strongest quarters ever”, although the group’s “problem child” turbine-making subsidiary Siemens ...

“Today, we are embarking on a new era, creating, alongside Siemens, a world-leading wind player”, said Ignacio Martín, Executive Chairman and Gamesa CEO “The combination of our wind ...

We expect these trends to persist, but are cognizant of the uncertainty surrounding the Siemens Gamesa division. Siemens Gamesa made a second-quarter loss of EUR 360 million. While the loss is ...

Transformation of Industry Revenue: 10.5% growth year-over-year. Siemens Gamesa Revenue: EUR2.7 billion, a 16% increase year-over-year. Siemens Gamesa Profit Before Special Items: Negative EUR249 ...

TPG Inc. is actively negotiating the acquisition of Indian wind energy assets of Gamesa, a subsidiary of German Siemens Energy AG. This is reported in a press release from Siemens Energy. As part of ...

Siemens Gamesa, while still in loss territory, showed signs of improvement. Revenue increased, largely driven by offshore wind, though ongoing challenges in onshore turbines and offshore ramp-up ...

Siemens Energy reported a robust second quarter in 2025, with revenue reaching €10 billion, marking a 20% year-over-year increase. The company also raised its full-year guidance across all key ...

In partnership with Siemens Gamesa Renewable Energy, our team developed an Ultra-Wideband sensing system to measure the deflections of turbine blades during transportation. Throughout the research and ...

Siemens Energy reported a fivefold increase ... year 2025 despite ongoing challenges at its turbine-maker subsidiary Gamesa. The renewable energy company posted a quarterly profit of €501 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

WARREN, N.J., May 5, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced results from the Phase 2 PIVOT-HD study of PTC518 (votoplam) in Stage 2 and Stage 3 Huntington's ...